Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (PEG)-BHD1028

Clinical trial NCT06563115 · COMPLETED

Trial details

NCT number: NCT06563115
Sponsor: EncuraGen, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Insulin Resistance

Start date: 2022-04-18
Primary completion: 2024-04-23
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.